Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.InVitria Launches New Cell Culture Supplement For CHO
InVitria has launched a new cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO at the 9th Protein Expression in Animal Cells (PEACe) Conference
InVitria has launched a new cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO at the 9th Protein Expression in Animal Cells (PEACe) Conference
Frutarom has announced a new satiety and obesity study using its FenuLife galactomannan ingredient and has revealed positive results. The company said that the study revealed an increase
Keryx Biopharmaceuticals has announced results of the Open Label Extension (OLE) trial of Zerenex for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage
Bayer HealthCare and Onyx Pharmaceuticals have announced the full results from the randomised, double-blind, placebo controlled phase II trial showing that Nexavar (sorafenib tablets) in combination with the
Oxygen Biotherapeutics has received approval from Israel’s Ministry of Health to begin a phase II-b, dose escalation, clinical trial in the country for use of Oxycyte in traumatic
Gerresheimer, a pharmaceutical packaging manufacturer, has opened a R&D center in the US. It has also inaugurated a new factory in Spain for plastic drugs packaging. The company
Vetter, a provider of Pre-filled Injection Systems, will open Vetter Development Service (VDS), a technologically advanced customer service facility located in Chicago, allowing the company to focus on
Q Chip, a biopharmaceutical drug delivery company, is developing a range of sustained-release biosimilars using its patented Q-Sphera bioencapsulation platform. Q-Sphera is an enabling technology for peptide and
“We are very excited about this agreement as it will launch us into the worldwide bovine tuberculosis testing market. This affliction costs the worldwide cattle industry billions of
Nutra Pharma plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in